Brian Feingold

Summary

Affiliation: Children's Hospital of Pittsburgh
Country: USA

Publications

  1. ncbi Survival in allosensitized children after listing for cardiac transplantation
    Brian Feingold
    Division of Pediatric Cardiology and Cardiopulmonary Transplantation, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 26:565-71. 2007
  2. pmc Outcomes after listing with a requirement for a prospective crossmatch in pediatric heart transplantation
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    J Heart Lung Transplant 32:56-62. 2013
  3. pmc Renal function and genetic polymorphisms in pediatric heart transplant recipients
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
    J Heart Lung Transplant 31:1003-8. 2012
  4. pmc Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    Pediatr Transplant 15:699-705. 2011
  5. doi Expression of A and B blood group antigens on cryopreserved homografts
    Brian Feingold
    Department of Pediatric Cardiology, Children s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 87:211-4. 2009
  6. pmc Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy
    Brian Feingold
    Division of Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
    J Card Fail 16:734-41. 2010
  7. pmc Tolerance to incompatible ABO blood group antigens is not observed following homograft implantation
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    Hum Immunol 72:835-40. 2011
  8. pmc Prognostic significance of recurrent grade 1B rejection in the first year after pediatric cardiac transplantation: a case for reinstatement of the 1B rejection grade
    Brian Feingold
    Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
    Pediatr Transplant 15:589-93. 2011
  9. pmc Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation
    Ying Xu
    University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    J Heart Lung Transplant 32:92-7. 2013
  10. pmc Multiple listing for pediatric heart transplantation in the U.S.A.: analysis of OPTN registry data from 1995 through 2009
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA Clinical and Translational Research, University of Pittsburgh, Pittsburgh, PA, USA
    Pediatr Transplant 17:787-93. 2013

Detail Information

Publications15

  1. ncbi Survival in allosensitized children after listing for cardiac transplantation
    Brian Feingold
    Division of Pediatric Cardiology and Cardiopulmonary Transplantation, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 26:565-71. 2007
    ..Little is known about the effect of pre-transplant alloantibody in the pediatric cardiac transplant population...
  2. pmc Outcomes after listing with a requirement for a prospective crossmatch in pediatric heart transplantation
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    J Heart Lung Transplant 32:56-62. 2013
    ..However, there are no reports of heart transplant candidate outcomes according to prospective crossmatch requirements...
  3. pmc Renal function and genetic polymorphisms in pediatric heart transplant recipients
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
    J Heart Lung Transplant 31:1003-8. 2012
    ..In this multicenter study, we investigated the association of genetic polymorphisms (GPs) in a panel of candidate genes on renal function in 453 pediatric heart transplant recipients...
  4. pmc Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    Pediatr Transplant 15:699-705. 2011
    ..Decreased eGFR at one yr post-HTx, but not at HTx, predicts onset of late renal dysfunction. Future research on strategies to minimize late renal dysfunction after pediatric HTx may be of greatest benefit if focused on these subgroups...
  5. doi Expression of A and B blood group antigens on cryopreserved homografts
    Brian Feingold
    Department of Pediatric Cardiology, Children s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 87:211-4. 2009
    ..It has been shown that there is lack of expression of A and B blood group antigens on fresh and cryopreserved homograft valves. However, expression of these antigens on the homograft vessel conduit has not been reported...
  6. pmc Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy
    Brian Feingold
    Division of Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
    J Card Fail 16:734-41. 2010
    ..Because of differences in heart failure etiology, sudden death rates, and ICD complication rates, these findings may not be applicable to children...
  7. pmc Tolerance to incompatible ABO blood group antigens is not observed following homograft implantation
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
    Hum Immunol 72:835-40. 2011
    ..These data suggest that tolerance to incompatible A and B blood group antigens does not occur following placement of ABO-incompatible homografts in childhood...
  8. pmc Prognostic significance of recurrent grade 1B rejection in the first year after pediatric cardiac transplantation: a case for reinstatement of the 1B rejection grade
    Brian Feingold
    Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA
    Pediatr Transplant 15:589-93. 2011
    ..90; p = 0.002) and the composite outcome (HR 4.52; p = 0.002). These data suggest that further study of the impact of removal of the 1B classification from the ISHLT grading scheme is warranted...
  9. pmc Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation
    Ying Xu
    University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
    J Heart Lung Transplant 32:92-7. 2013
    ..In this study we sought to evaluate the utility of routine C4d immunostaining in the first year after pediatric and young adult HTx...
  10. pmc Multiple listing for pediatric heart transplantation in the U.S.A.: analysis of OPTN registry data from 1995 through 2009
    Brian Feingold
    Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA Clinical and Translational Research, University of Pittsburgh, Pittsburgh, PA, USA
    Pediatr Transplant 17:787-93. 2013
    ..single-listed patients (40%, 54%, 64%; p = 0.11). Multiple listing for pediatric heart transplantation in the USA occurs infrequently and is more common in patients with private insurance. ..
  11. pmc Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients
    Adriana Zeevi
    Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 32:98-105. 2013
    ..A novel Luminex SAB-based assay detecting C1q-binding HLA antibodies (SAB-C1q) contributes functional information to SAB testing, but the relationship between SAB strength and complement-binding ability is unclear...
  12. pmc Left ventricular myocardial performance index change for detection of acute cellular rejection in pediatric heart transplantation
    Ryan Flanagan
    Division of Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA Womack Army Medical Center, Fort Bragg, NC, USA
    Pediatr Transplant 17:782-6. 2013
    ..Future studies in larger, prospective cohorts should be undertaken to validate these findings. ..
  13. ncbi Characterization of c4d immunostaining utilizing paraffin-embedded tissue of nonpresensitized pediatric heart transplant patients
    Csaba Galambos
    Department of Pathology, Children s Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Pediatr Dev Pathol 11:181-4. 2008
    ..Contrary to previously reported data, none of the ischemic/reperfusion injury endomyocardial biopsy samples was C4d+, and histologic features alone were poor predictors of C4d+...
  14. doi Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient
    Adriana Zeevi
    University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Hum Immunol 73:48-51. 2012
    ..Our findings illustrate the usefulness of determining antibody specificities against epitopes using various Luminex-based assays...
  15. ncbi Heart transplantation: Literature review 2003-2004
    Brian Feingold
    Division of Cardiology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Pediatr Transplant 9:430-9. 2005
    ..In this review, we summarize important articles in the field of pediatric heart transplantation that have been published over the last 2 years (2003, 2004). The review is intended to be comprehensive but not exhaustive...